img

Global Transdermal Scopolamine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Transdermal Scopolamine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Transdermal Scopolamine report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Transdermal Scopolamine market is projected to reach US$ 539.4 million in 2034, increasing from US$ 390.5 million in 2022, with the CAGR of 4.6% during the period of 2024 to 2034. Demand from Narcotic Analgesia and Cough are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Transdermal Scopolamine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Transdermal Scopolamine key manufacturers include Baxter International, GlaxoSmithKline, Novartis AG, Perrigo Company, Caleb Pharmaceuticals, Myungmoon Pharma, Pfizer and Nichi-Iko, etc. Baxter International, GlaxoSmithKline, Novartis AG are top 3 players and held % sales share in total in 2022.
Transdermal Scopolamine can be divided into Tablet Type, Syrups Type, Injections Type and Patch Type, etc. Tablet Type is the mainstream product in the market, accounting for % sales share globally in 2022.
Transdermal Scopolamine is widely used in various fields, such as Narcotic Analgesia, Cough, Asthma and Motion Sickness, etc. Narcotic Analgesia provides greatest supports to the Transdermal Scopolamine industry development. In 2022, global % sales of Transdermal Scopolamine went into Narcotic Analgesia filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Transdermal Scopolamine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Baxter International
GlaxoSmithKline
Novartis AG
Perrigo Company
Caleb Pharmaceuticals
Myungmoon Pharma
Pfizer
Nichi-Iko
Segment by Type
Tablet Type
Syrups Type
Injections Type
Patch Type
Gel Type

Segment by Application


Narcotic Analgesia
Cough
Asthma
Motion Sickness
Parkinson's Disease
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Transdermal Scopolamine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Transdermal Scopolamine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Transdermal Scopolamine industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Transdermal Scopolamine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Transdermal Scopolamine introduction, etc. Transdermal Scopolamine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Transdermal Scopolamine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Transdermal Scopolamine Market Overview
1.1 Transdermal Scopolamine Product Overview
1.2 Transdermal Scopolamine Market Segment by Type
1.2.1 Tablet Type
1.2.2 Syrups Type
1.2.3 Injections Type
1.2.4 Patch Type
1.2.5 Gel Type
1.3 Global Transdermal Scopolamine Market Size by Type
1.3.1 Global Transdermal Scopolamine Market Size Overview by Type (2018-2034)
1.3.2 Global Transdermal Scopolamine Historic Market Size Review by Type (2018-2024)
1.3.3 Global Transdermal Scopolamine Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Transdermal Scopolamine Sales Breakdown by Type (2018-2024)
1.4.2 Europe Transdermal Scopolamine Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Transdermal Scopolamine Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Transdermal Scopolamine Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Transdermal Scopolamine Sales Breakdown by Type (2018-2024)
2 Global Transdermal Scopolamine Market Competition by Company
2.1 Global Top Players by Transdermal Scopolamine Sales (2018-2024)
2.2 Global Top Players by Transdermal Scopolamine Revenue (2018-2024)
2.3 Global Top Players by Transdermal Scopolamine Price (2018-2024)
2.4 Global Top Manufacturers Transdermal Scopolamine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Transdermal Scopolamine Market Competitive Situation and Trends
2.5.1 Transdermal Scopolamine Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Transdermal Scopolamine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Transdermal Scopolamine as of 2022)
2.7 Date of Key Manufacturers Enter into Transdermal Scopolamine Market
2.8 Key Manufacturers Transdermal Scopolamine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Transdermal Scopolamine Status and Outlook by Region
3.1 Global Transdermal Scopolamine Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Transdermal Scopolamine Historic Market Size by Region
3.2.1 Global Transdermal Scopolamine Sales in Volume by Region (2018-2024)
3.2.2 Global Transdermal Scopolamine Sales in Value by Region (2018-2024)
3.2.3 Global Transdermal Scopolamine Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Transdermal Scopolamine Forecasted Market Size by Region
3.3.1 Global Transdermal Scopolamine Sales in Volume by Region (2024-2034)
3.3.2 Global Transdermal Scopolamine Sales in Value by Region (2024-2034)
3.3.3 Global Transdermal Scopolamine Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Transdermal Scopolamine by Application
4.1 Transdermal Scopolamine Market Segment by Application
4.1.1 Narcotic Analgesia
4.1.2 Cough
4.1.3 Asthma
4.1.4 Motion Sickness
4.1.5 Parkinson's Disease
4.1.6 Others
4.2 Global Transdermal Scopolamine Market Size by Application
4.2.1 Global Transdermal Scopolamine Market Size Overview by Application (2018-2034)
4.2.2 Global Transdermal Scopolamine Historic Market Size Review by Application (2018-2024)
4.2.3 Global Transdermal Scopolamine Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Transdermal Scopolamine Sales Breakdown by Application (2018-2024)
4.3.2 Europe Transdermal Scopolamine Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Transdermal Scopolamine Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Transdermal Scopolamine Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Transdermal Scopolamine Sales Breakdown by Application (2018-2024)
5 North America Transdermal Scopolamine by Country
5.1 North America Transdermal Scopolamine Historic Market Size by Country
5.1.1 North America Transdermal Scopolamine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Transdermal Scopolamine Sales in Volume by Country (2018-2024)
5.1.3 North America Transdermal Scopolamine Sales in Value by Country (2018-2024)
5.2 North America Transdermal Scopolamine Forecasted Market Size by Country
5.2.1 North America Transdermal Scopolamine Sales in Volume by Country (2024-2034)
5.2.2 North America Transdermal Scopolamine Sales in Value by Country (2024-2034)
6 Europe Transdermal Scopolamine by Country
6.1 Europe Transdermal Scopolamine Historic Market Size by Country
6.1.1 Europe Transdermal Scopolamine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Transdermal Scopolamine Sales in Volume by Country (2018-2024)
6.1.3 Europe Transdermal Scopolamine Sales in Value by Country (2018-2024)
6.2 Europe Transdermal Scopolamine Forecasted Market Size by Country
6.2.1 Europe Transdermal Scopolamine Sales in Volume by Country (2024-2034)
6.2.2 Europe Transdermal Scopolamine Sales in Value by Country (2024-2034)
7 Asia-Pacific Transdermal Scopolamine by Region
7.1 Asia-Pacific Transdermal Scopolamine Historic Market Size by Region
7.1.1 Asia-Pacific Transdermal Scopolamine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Transdermal Scopolamine Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Transdermal Scopolamine Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Transdermal Scopolamine Forecasted Market Size by Region
7.2.1 Asia-Pacific Transdermal Scopolamine Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Transdermal Scopolamine Sales in Value by Region (2024-2034)
8 Latin America Transdermal Scopolamine by Country
8.1 Latin America Transdermal Scopolamine Historic Market Size by Country
8.1.1 Latin America Transdermal Scopolamine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Transdermal Scopolamine Sales in Volume by Country (2018-2024)
8.1.3 Latin America Transdermal Scopolamine Sales in Value by Country (2018-2024)
8.2 Latin America Transdermal Scopolamine Forecasted Market Size by Country
8.2.1 Latin America Transdermal Scopolamine Sales in Volume by Country (2024-2034)
8.2.2 Latin America Transdermal Scopolamine Sales in Value by Country (2024-2034)
9 Middle East and Africa Transdermal Scopolamine by Country
9.1 Middle East and Africa Transdermal Scopolamine Historic Market Size by Country
9.1.1 Middle East and Africa Transdermal Scopolamine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Transdermal Scopolamine Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Transdermal Scopolamine Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Transdermal Scopolamine Forecasted Market Size by Country
9.2.1 Middle East and Africa Transdermal Scopolamine Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Transdermal Scopolamine Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Baxter International
10.1.1 Baxter International Company Information
10.1.2 Baxter International Introduction and Business Overview
10.1.3 Baxter International Transdermal Scopolamine Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Baxter International Transdermal Scopolamine Products Offered
10.1.5 Baxter International Recent Development
10.2 GlaxoSmithKline
10.2.1 GlaxoSmithKline Company Information
10.2.2 GlaxoSmithKline Introduction and Business Overview
10.2.3 GlaxoSmithKline Transdermal Scopolamine Sales, Revenue and Gross Margin (2018-2024)
10.2.4 GlaxoSmithKline Transdermal Scopolamine Products Offered
10.2.5 GlaxoSmithKline Recent Development
10.3 Novartis AG
10.3.1 Novartis AG Company Information
10.3.2 Novartis AG Introduction and Business Overview
10.3.3 Novartis AG Transdermal Scopolamine Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Novartis AG Transdermal Scopolamine Products Offered
10.3.5 Novartis AG Recent Development
10.4 Perrigo Company
10.4.1 Perrigo Company Company Information
10.4.2 Perrigo Company Introduction and Business Overview
10.4.3 Perrigo Company Transdermal Scopolamine Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Perrigo Company Transdermal Scopolamine Products Offered
10.4.5 Perrigo Company Recent Development
10.5 Caleb Pharmaceuticals
10.5.1 Caleb Pharmaceuticals Company Information
10.5.2 Caleb Pharmaceuticals Introduction and Business Overview
10.5.3 Caleb Pharmaceuticals Transdermal Scopolamine Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Caleb Pharmaceuticals Transdermal Scopolamine Products Offered
10.5.5 Caleb Pharmaceuticals Recent Development
10.6 Myungmoon Pharma
10.6.1 Myungmoon Pharma Company Information
10.6.2 Myungmoon Pharma Introduction and Business Overview
10.6.3 Myungmoon Pharma Transdermal Scopolamine Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Myungmoon Pharma Transdermal Scopolamine Products Offered
10.6.5 Myungmoon Pharma Recent Development
10.7 Pfizer
10.7.1 Pfizer Company Information
10.7.2 Pfizer Introduction and Business Overview
10.7.3 Pfizer Transdermal Scopolamine Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Pfizer Transdermal Scopolamine Products Offered
10.7.5 Pfizer Recent Development
10.8 Nichi-Iko
10.8.1 Nichi-Iko Company Information
10.8.2 Nichi-Iko Introduction and Business Overview
10.8.3 Nichi-Iko Transdermal Scopolamine Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Nichi-Iko Transdermal Scopolamine Products Offered
10.8.5 Nichi-Iko Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Transdermal Scopolamine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Transdermal Scopolamine Industrial Chain Analysis
11.4 Transdermal Scopolamine Market Dynamics
11.4.1 Transdermal Scopolamine Industry Trends
11.4.2 Transdermal Scopolamine Market Drivers
11.4.3 Transdermal Scopolamine Market Challenges
11.4.4 Transdermal Scopolamine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Transdermal Scopolamine Distributors
12.3 Transdermal Scopolamine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Tablet Type
Table 2. Major Company of Syrups Type
Table 3. Major Company of Injections Type
Table 4. Major Company of Patch Type
Table 5. Major Company of Gel Type
Table 6. Global Transdermal Scopolamine Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Transdermal Scopolamine Sales by Type (2018-2024) & (K Units)
Table 8. Global Transdermal Scopolamine Sales Market Share in Volume by Type (2018-2024)
Table 9. Global Transdermal Scopolamine Sales by Type (2018-2024) & (US& Million)
Table 10. Global Transdermal Scopolamine Market Share in Value by Type (2018-2024)
Table 11. Global Transdermal Scopolamine Price by Type (2018-2024) & (USD/Unit)
Table 12. Global Transdermal Scopolamine Sales by Type (2024-2034) & (K Units)
Table 13. Global Transdermal Scopolamine Sales Market Share in Volume by Type (2024-2034)
Table 14. Global Transdermal Scopolamine Sales by Type (2024-2034) & (US$ Million)
Table 15. Global Transdermal Scopolamine Sales Market Share in Value by Type (2024-2034)
Table 16. Global Transdermal Scopolamine Price by Type (2024-2034) & (USD/Unit)
Table 17. North America Transdermal Scopolamine Sales by Type (2018-2024) & (K Units)
Table 18. North America Transdermal Scopolamine Sales by Type (2018-2024) & (US$ Million)
Table 19. Europe Transdermal Scopolamine Sales (K Units) by Type (2018-2024)
Table 20. Europe Transdermal Scopolamine Sales by Type (2018-2024) & (US$ Million)
Table 21. Asia-Pacific Transdermal Scopolamine Sales (K Units) by Type (2018-2024)
Table 22. Asia-Pacific Transdermal Scopolamine Sales by Type (2018-2024) & (US$ Million)
Table 23. Latin America Transdermal Scopolamine Sales (K Units) by Type (2018-2024)
Table 24. Latin America Transdermal Scopolamine Sales by Type (2018-2024) & (US$ Million)
Table 25. Middle East and Africa Transdermal Scopolamine Sales (K Units) by Type (2018-2024)
Table 26. Middle East and Africa Transdermal Scopolamine Sales by Type (2018-2024) & (US$ Million)
Table 27. Global Transdermal Scopolamine Sales by Company (2018-2024) & (K Units)
Table 28. Global Transdermal Scopolamine Sales Share by Company (2018-2024)
Table 29. Global Transdermal Scopolamine Revenue by Company (2018-2024) & (US$ Million)
Table 30. Global Transdermal Scopolamine Revenue Share by Company (2018-2024)
Table 31. Global Market Transdermal Scopolamine Price by Company (2018-2024) & (USD/Unit)
Table 32. Global Transdermal Scopolamine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global Transdermal Scopolamine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Transdermal Scopolamine as of 2022)
Table 35. Date of Key Manufacturers Enter into Transdermal Scopolamine Market
Table 36. Key Manufacturers Transdermal Scopolamine Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Transdermal Scopolamine Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 39. Global Transdermal Scopolamine Sales by Region (2018-2024) & (K Units)
Table 40. Global Transdermal Scopolamine Sales Market Share in Volume by Region (2018-2024)
Table 41. Global Transdermal Scopolamine Sales by Region (2018-2024) & (US$ Million)
Table 42. Global Transdermal Scopolamine Sales Market Share in Value by Region (2018-2024)
Table 43. Global Transdermal Scopolamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 44. Global Transdermal Scopolamine Sales by Region (2024-2034) & (K Units)
Table 45. Global Transdermal Scopolamine Sales Market Share in Volume by Region (2024-2034)
Table 46. Global Transdermal Scopolamine Sales by Region (2024-2034) & (US$ Million)
Table 47. Global Transdermal Scopolamine Sales Market Share in Value by Region (2024-2034)
Table 48. Global Transdermal Scopolamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 49. Global Transdermal Scopolamine Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 50. Global Transdermal Scopolamine Sales by Application (2018-2024) & (K Units)
Table 51. Global Transdermal Scopolamine Sales Market Share in Volume by Application (2018-2024)
Table 52. Global Transdermal Scopolamine Sales by Application (2018-2024) & (US$ Million)
Table 53. Global Transdermal Scopolamine Sales Market Share in Value by Application (2018-2024)
Table 54. Global Transdermal Scopolamine Price by Application (2018-2024) & (USD/Unit)
Table 55. Global Transdermal Scopolamine Sales by Application (2024-2034) & (K Units)
Table 56. Global Transdermal Scopolamine Sales Market Share in Volume by Application (2024-2034)
Table 57. Global Transdermal Scopolamine Sales by Application (2024-2034) & (US$ Million)
Table 58. Global Transdermal Scopolamine Sales Market Share in Value by Application (2024-2034)
Table 59. Global Transdermal Scopolamine Price by Application (2024-2034) & (USD/Unit)
Table 60. North America Transdermal Scopolamine Sales by Application (2018-2024) (K Units)
Table 61. North America Transdermal Scopolamine Sales by Application (2018-2024) & (US$ Million)
Table 62. Europe Transdermal Scopolamine Sales by Application (2018-2024) (K Units)
Table 63. Europe Transdermal Scopolamine Sales by Application (2018-2024) & (US$ Million)
Table 64. Asia-Pacific Transdermal Scopolamine Sales by Application (2018-2024) (K Units)
Table 65. Asia-Pacific Transdermal Scopolamine Sales by Application (2018-2024) & (US$ Million)
Table 66. Latin America Transdermal Scopolamine Sales by Application (2018-2024) (K Units)
Table 67. Latin America Transdermal Scopolamine Sales by Application (2018-2024) & (US$ Million)
Table 68. Middle East and Africa Transdermal Scopolamine Sales by Application (2018-2024) (K Units)
Table 69. Middle East and Africa Transdermal Scopolamine Sales by Application (2018-2024) & (US$ Million)
Table 70. North America Transdermal Scopolamine Sales by Country (2018-2024) & (K Units)
Table 71. North America Transdermal Scopolamine Sales Market Share in Volume by Country (2018-2024)
Table 72. North America Transdermal Scopolamine Sales by Country (2018-2024) & (US$ Million)
Table 73. North America Transdermal Scopolamine Sales Market Share in Value by Country (2018-2024)
Table 74. North America Transdermal Scopolamine Sales by Country (2024-2034) & (K Units)
Table 75. North America Transdermal Scopolamine Sales Market Share in Volume by Country (2024-2034)
Table 76. North America Transdermal Scopolamine Sales by Country (2024-2034) & (US$ Million)
Table 77. North America Transdermal Scopolamine Sales Market Share in Value by Country (2024-2034)
Table 78. Europe Transdermal Scopolamine Sales by Country (2018-2024) & (K Units)
Table 79. Europe Transdermal Scopolamine Sales Market Share in Volume by Country (2018-2024)
Table 80. Europe Transdermal Scopolamine Sales by Country (2018-2024) & (US$ Million)
Table 81. Europe Transdermal Scopolamine Sales Market Share in Value by Country (2018-2024)
Table 82. Europe Transdermal Scopolamine Sales by Country (2024-2034) & (K Units)
Table 83. Europe Transdermal Scopolamine Sales Market Share in Volume by Country (2024-2034)
Table 84. Europe Transdermal Scopolamine Sales by Country (2024-2034) & (US$ Million)
Table 85. Europe Transdermal Scopolamine Sales Market Share in Value by Country (2024-2034)
Table 86. Asia-Pacific Transdermal Scopolamine Sales by Region (2018-2024) & (K Units)
Table 87. Asia-Pacific Transdermal Scopolamine Sales Market Share in Volume by Region (2018-2024)
Table 88. Asia-Pacific Transdermal Scopolamine Sales by Region (2018-2024) & (US$ Million)
Table 89. Asia-Pacific Transdermal Scopolamine Sales Market Share in Value by Region (2018-2024)
Table 90. Asia-Pacific Transdermal Scopolamine Sales by Region (2024-2034) & (K Units)
Table 91. Asia-Pacific Transdermal Scopolamine Sales Market Share in Volume by Region (2024-2034)
Table 92. Asia-Pacific Transdermal Scopolamine Sales by Region (2024-2034) & (US$ Million)
Table 93. Asia-Pacific Transdermal Scopolamine Sales Market Share in Value by Region (2024-2034)
Table 94. Latin America Transdermal Scopolamine Sales by Country (2018-2024) & (K Units)
Table 95. Latin America Transdermal Scopolamine Sales Market Share in Volume by Country (2018-2024)
Table 96. Latin America Transdermal Scopolamine Sales by Country (2018-2024) & (US$ Million)
Table 97. Latin America Transdermal Scopolamine Sales Market Share in Value by Country (2018-2024)
Table 98. Latin America Transdermal Scopolamine Sales by Country (2024-2034) & (K Units)
Table 99. Latin America Transdermal Scopolamine Sales Market Share in Volume by Country (2024-2034)
Table 100. Latin America Transdermal Scopolamine Sales by Country (2024-2034) & (US$ Million)
Table 101. Latin America Transdermal Scopolamine Sales Market Share in Value by Country (2024-2034)
Table 102. Middle East and Africa Transdermal Scopolamine Sales by Country (2018-2024) & (K Units)
Table 103. Middle East and Africa Transdermal Scopolamine Sales Market Share in Volume by Country (2018-2024)
Table 104. Middle East and Africa Transdermal Scopolamine Sales by Country (2018-2024) & (US$ Million)
Table 105. Middle East and Africa Transdermal Scopolamine Sales Market Share in Value by Country (2018-2024)
Table 106. Middle East and Africa Transdermal Scopolamine Sales by Country (2024-2034) & (K Units)
Table 107. Middle East and Africa Transdermal Scopolamine Sales Market Share in Volume by Country (2024-2034)
Table 108. Middle East and Africa Transdermal Scopolamine Sales by Country (2024-2034) & (US$ Million)
Table 109. Middle East and Africa Transdermal Scopolamine Sales Market Share in Value by Country (2024-2034)
Table 110. Baxter International Company Information
Table 111. Baxter International Introduction and Business Overview
Table 112. Baxter International Transdermal Scopolamine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 113. Baxter International Transdermal Scopolamine Product
Table 114. Baxter International Recent Development
Table 115. GlaxoSmithKline Company Information
Table 116. GlaxoSmithKline Introduction and Business Overview
Table 117. GlaxoSmithKline Transdermal Scopolamine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 118. GlaxoSmithKline Transdermal Scopolamine Product
Table 119. GlaxoSmithKline Recent Development
Table 120. Novartis AG Company Information
Table 121. Novartis AG Introduction and Business Overview
Table 122. Novartis AG Transdermal Scopolamine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 123. Novartis AG Transdermal Scopolamine Product
Table 124. Novartis AG Recent Development
Table 125. Perrigo Company Company Information
Table 126. Perrigo Company Introduction and Business Overview
Table 127. Perrigo Company Transdermal Scopolamine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 128. Perrigo Company Transdermal Scopolamine Product
Table 129. Perrigo Company Recent Development
Table 130. Caleb Pharmaceuticals Company Information
Table 131. Caleb Pharmaceuticals Introduction and Business Overview
Table 132. Caleb Pharmaceuticals Transdermal Scopolamine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 133. Caleb Pharmaceuticals Transdermal Scopolamine Product
Table 134. Caleb Pharmaceuticals Recent Development
Table 135. Myungmoon Pharma Company Information
Table 136. Myungmoon Pharma Introduction and Business Overview
Table 137. Myungmoon Pharma Transdermal Scopolamine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 138. Myungmoon Pharma Transdermal Scopolamine Product
Table 139. Myungmoon Pharma Recent Development
Table 140. Pfizer Company Information
Table 141. Pfizer Introduction and Business Overview
Table 142. Pfizer Transdermal Scopolamine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 143. Pfizer Transdermal Scopolamine Product
Table 144. Pfizer Recent Development
Table 145. Nichi-Iko Company Information
Table 146. Nichi-Iko Introduction and Business Overview
Table 147. Nichi-Iko Transdermal Scopolamine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 148. Nichi-Iko Transdermal Scopolamine Product
Table 149. Nichi-Iko Recent Development
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Transdermal Scopolamine Market Trends
Table 153. Transdermal Scopolamine Market Drivers
Table 154. Transdermal Scopolamine Market Challenges
Table 155. Transdermal Scopolamine Market Restraints
Table 156. Transdermal Scopolamine Distributors List
Table 157. Transdermal Scopolamine Downstream Customers
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Transdermal Scopolamine Product Picture
Figure 2. Global Transdermal Scopolamine Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Transdermal Scopolamine Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Transdermal Scopolamine Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Tablet Type
Figure 6. Global Tablet Type Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Syrups Type
Figure 8. Global Syrups Type Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Product Picture of Injections Type
Figure 10. Global Injections Type Sales YoY Growth (2018-2034) & (K Units)
Figure 11. Product Picture of Patch Type
Figure 12. Global Patch Type Sales YoY Growth (2018-2034) & (K Units)
Figure 13. Product Picture of Gel Type
Figure 14. Global Gel Type Sales YoY Growth (2018-2034) & (K Units)
Figure 15. Global Transdermal Scopolamine Sales by Type (2018-2034) & (US$ Million)
Figure 16. Global Transdermal Scopolamine Sales Market Share by Type in 2022 & 2034
Figure 17. North America Transdermal Scopolamine Sales Market Share in Volume by Type in 2022
Figure 18. North America Transdermal Scopolamine Sales Market Share in Value by Type in 2022
Figure 19. Europe Transdermal Scopolamine Sales Market Share in Volume by Type in 2022
Figure 20. Europe Transdermal Scopolamine Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific Transdermal Scopolamine Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific Transdermal Scopolamine Sales Market Share in Value by Type in 2022
Figure 23. Latin America Transdermal Scopolamine Sales Market Share in Volume by Type in 2022
Figure 24. Latin America Transdermal Scopolamine Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa Transdermal Scopolamine Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa Transdermal Scopolamine Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Transdermal Scopolamine Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Transdermal Scopolamine Revenue in 2022
Figure 29. Transdermal Scopolamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Product Picture of Narcotic Analgesia
Figure 31. Global Narcotic Analgesia Sales YoY Growth (2018-2034) & (K Units)
Figure 32. Product Picture of Cough
Figure 33. Global Cough Sales YoY Growth (2018-2034) & (K Units)
Figure 34. Product Picture of Asthma
Figure 35. Global Asthma Sales YoY Growth (2018-2034) & (K Units)
Figure 36. Product Picture of Motion Sickness
Figure 37. Global Motion Sickness Sales YoY Growth (2018-2034) & (K Units)
Figure 38. Product Picture of Parkinson's Disease
Figure 39. Global Parkinson's Disease Sales YoY Growth (2018-2034) & (K Units)
Figure 40. Product Picture of Others
Figure 41. Global Others Sales YoY Growth (2018-2034) & (K Units)
Figure 42. Global Transdermal Scopolamine Sales by Application (2018-2034) & (US$ Million)
Figure 43. Global Transdermal Scopolamine Sales Market Share by Application in 2022 & 2034
Figure 44. North America Transdermal Scopolamine Sales Market Share in Volume by Application in 2022
Figure 45. North America Transdermal Scopolamine Sales Market Share in Value by Application in 2022
Figure 46. Europe Transdermal Scopolamine Sales Market Share in Volume by Application in 2022
Figure 47. Europe Transdermal Scopolamine Sales Market Share in Value by Application in 2022
Figure 48. Asia-Pacific Transdermal Scopolamine Sales Market Share in Volume by Application in 2022
Figure 49. Asia-Pacific Transdermal Scopolamine Sales Market Share in Value by Application in 2022
Figure 50. Latin America Transdermal Scopolamine Sales Market Share in Volume by Application in 2022
Figure 51. Latin America Transdermal Scopolamine Sales Market Share in Value by Application in 2022
Figure 52. Middle East and Africa Transdermal Scopolamine Sales Market Share in Value by Application in 2022
Figure 53. Key Raw Materials Price
Figure 54. Transdermal Scopolamine Manufacturing Cost Structure
Figure 55. Transdermal Scopolamine Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries